Barbara Sue Wiggins

Title
InstitutionMedical University of South Carolina
DepartmentCOP Clinical Pharmacy and Outcome Sciences - MUSC Campus
AddressP.O. Box MSC 584
Phone843-876-5597
Fax843-792-0566
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dixon DL, Patel J, Spence R, Talasaz AH, Abbate A, Wiggins BS, Dixon DL, Patel J, Spence R, Talasaz AH, Abbate A, Wiggins BS. Select drug-drug interactions with colchicine and cardiovascular medications: A review. Am Heart J. 2022 10; 252:42-50. PMID: 35714680.
      Citations:    Fields:    Translation:Humans
    2. Wiggins BS, Backes JM, Hilleman D, Wiggins BS, Backes JM, Hilleman D. Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care. Pharmacotherapy. 2022 05; 42(5):428-438. PMID: 35388918.
      Citations: 1     Fields:    Translation:Humans
    3. Wiggins BS, Wiggins BS. Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia. J Cardiovasc Pharmacol. 2021 11 01; 78(5):e631-e640. PMID: 34738550.
      Citations:    
    4. Wiethorn EE, Bell CM, Wiggins BS, Wiethorn EE, Bell CM, Wiggins BS. Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing = 120 Kilograms versus 60-120 Kilograms. Am J Cardiovasc Drugs. 2021 Sep; 21(5):545-551. PMID: 33782909.
      Citations:    
    5. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Gluckman TJ, Hucker WJ, Mehran R, Messé SR, Perino AC, Rodriguez F, Sarode R, Siegal DM, Wiggins BS, Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Gluckman TJ, Hucker WJ, Mehran R, Mess? SR, Perino AC, Rodriguez F, Sarode R, Siegal DM, Wiggins BS. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 08 04; 76(5):594-622. PMID: 32680646.
      Citations:    
    6. Hilleman DE, Wiggins BS, Bottorff MB, Hilleman DE, Wiggins BS, Bottorff MB. A Response to: Letter to the Editor Regarding "Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review". Adv Ther. 2020 09; 37(9):4046-4048. PMID: 32647913; PMCID: PMC7444398.
      Citations:    
    7. Wiggins BS, Dixon DL, Neyens RR, Page RL, Gluckman TJ, Wiggins BS, Dixon DL, Neyens RR, Page RL, Gluckman TJ. Select Drug-Drug Interactions With Direct?Oral Anticoagulants: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 03 24; 75(11):1341-1350. PMID: 32192661.
      Citations:    
    8. Hilleman DE, Wiggins BS, Bottorff MB, Hilleman DE, Wiggins BS, Bottorff MB. Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review. Adv Ther. 2020 02; 37(2):656-670. PMID: 31919792; PMCID: PMC6999166.
      Citations:    
    9. Kabulski GM, Northup A, Wiggins BS, Kabulski GM, Northup A, Wiggins BS. Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement. J Innov Card Rhythm Manag. 2019 Aug; 10(8):3777-3784. PMID: 32477744; PMCID: PMC7252755.
      Citations:    
    10. Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R, Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894. PMID: 31401932.
      Citations:    
    11. Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS, Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 12 25; 72(25):3332-3365. PMID: 30527452.
      Citations:    
    12. Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS, Writing Committee Members, Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, ACC Task Force On Expert Consensus Decision Pathways, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection. Catheter Cardiovasc Interv. 2018 08 01; 92(2):222-246. PMID: 30160001.
      Citations:    
    13. Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS, Writing Committee Members, Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, ACC Task Force on Expert Consensus Decision Pathways, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts. Catheter Cardiovasc Interv. 2018 08 01; 92(2):203-221. PMID: 30160013.
      Citations:    
    14. Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS, Writing Committee Members, Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, ACC Task Force On Expert Consensus Decision Pathways, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness. Catheter Cardiovasc Interv. 2018 08 01; 92(2):E35-E97. PMID: 30160063.
      Citations:    
    15. Wiggins BS, Senfield J, Kassahun H, Lira A, Somaratne R, Wiggins BS, Senfield J, Kassahun H, Lira A, Somaratne R. Evolocumab: Considerations for the Management of Hyperlipidemia. Curr Atheroscler Rep. 2018 03 06; 20(4):17. PMID: 29511875.
      Citations:    
    16. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV, Rodriguez F, Sarode R, Siegal D, Wiggins BS, Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Mess? SR, Pollack CV, Rodriguez F, Sarode R, Siegal D, Wiggins BS. 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017 Dec 19; 70(24):3042-3067. PMID: 29203195.
      Citations:    
    17. Wiggins BS, Lamprecht DG, Page RL, Saseen JJ, Wiggins BS, Lamprecht DG, Page RL, Saseen JJ. Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications. Am J Cardiovasc Drugs. 2017 Oct; 17(5):375-389. PMID: 28364370.
      Citations:    
    18. Floroff CK, Palm NM, Steinberg DH, Powers ER, Wiggins BS, Floroff CK, Palm NM, Steinberg DH, Powers ER, Wiggins BS. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Pharmacotherapy. 2017 Apr; 37(4):393-400. PMID: 28107569.
      Citations:    
    19. Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB, Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB, American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Co. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495. PMID: 27754879.
      Citations:    
    20. Wiggins BS, Saseen JJ, Morris PB, Wiggins BS, Saseen JJ, Morris PB. Gemfibrozil in Combination with Statins-Is It Really Contraindicated? Curr Atheroscler Rep. 2016 Apr; 18(4):18. PMID: 26932225.
      Citations:    
    21. Wiggins BS, Northup A, Johnson D, Senfield J, Wiggins BS, Northup A, Johnson D, Senfield J. Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin. Pharmacotherapy. 2016 Feb; 36(2):e5-7. PMID: 26846610.
      Citations:    
    22. Wiggins BS, Nappi J, Fortier CR, Taber DJ, Wiggins BS, Nappi J, Fortier CR, Taber DJ. Cardiovascular Drug Shortages: Predominant Etiologies, Clinical Implications, and Management Strategies. Ann Pharmacother. 2014 Sep; 48(9):1177-1186. PMID: 24915735.
      Citations:    
    23. Wiggins BS, Rodgers JE, DiDomenico RJ, Cook AM, Page RL, Wiggins BS, Rodgers JE, DiDomenico RJ, Cook AM, Page RL. Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative. Pharmacotherapy. 2013 May; 33(5):558-80. PMID: 23529897.
      Citations:    
    24. Jackevicius CA, Page RL, Chow S, Dunn SP, Lee CR, Ng TM, Rodgers JE, Vardeny O, Wiggins BS, Munger MA, Jackevicius CA, Page RL, Chow S, Dunn SP, Lee CR, Ng TM, Rodgers JE, Vardeny O, Wiggins BS, Munger MA. High-impact articles related to the management of heart failure: 2008 update. Pharmacotherapy. 2009 Jan; 29(1):82-120. PMID: 19113799.
      Citations:    
    25. Dobesh PP, Brouse SD, Dager WE, Spinler SA, Stacy Z, Wiggins BS, Dobesh PP, Brouse SD, Dager WE, Spinler SA, Stacy Z, Wiggins BS. Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update. Pharmacotherapy. 2007 Dec; 27(12):1722-58. PMID: 18041892.
      Citations:    
    26. Buck ML, Wiggins BS, Sesler JM, Buck ML, Wiggins BS, Sesler JM. Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Ann Pharmacother. 2007 Oct; 41(10):1679-86. PMID: 17698894.
      Citations:    
    27. Dager WE, Sanoski CA, Wiggins BS, Tisdale JE, Dager WE, Sanoski CA, Wiggins BS, Tisdale JE. Pharmacotherapy considerations in advanced cardiac life support. Pharmacotherapy. 2006 Dec; 26(12):1703-29. PMID: 17125434.
      Citations:    
    28. Orr RK, Hoehn JL, Col NF, Holtzman CW, Wiggins BS, Spinler SA. Role of P-glycoprotein in statin drug interactions. Pharmacotherapy. 2006 Nov; 26(11):1601-7. PMID: 17064205.
      Citations:    
    29. Levine GN, Berger PB, Cohen DJ, Maree AO, Rosenfield K, Wiggins BS, Spinler SA, Levine GN, Berger PB, Cohen DJ, Maree AO, Rosenfield K, Wiggins BS, Spinler SA. Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals. Pharmacotherapy. 2006 Nov; 26(11):1537-56. PMID: 17064198.
      Citations:    
    30. Ng TM, Carter O, Guillory GS, Howard PA, Lee CR, Rodgers JE, Uber PA, Wiggins BS, Munger MA, Patterson JH, Ng TM, Carter O, Guillory GS, Howard PA, Lee CR, Rodgers JE, Uber PA, Wiggins BS, Munger MA, Patterson JH. High-impact articles related to the pharmacotherapeutic management of systolic heart failure. Pharmacotherapy. 2004 Nov; 24(11):1594-633. PMID: 15537564.
      Citations:    
    31. Wiggins BS, Spinler S, Wittkowsky AK, Stringer KA, Wiggins BS, Spinler S, Wittkowsky AK, Stringer KA. Bivalirudin: a direct thrombin inhibitor for percutaneous transluminal coronary angioplasty. Pharmacotherapy. 2002 Aug; 22(8):1007-18. PMID: 12173785.
      Citations: 3     Fields:    Translation:Humans
    Wiggins's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (133)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _